REPORTS OF SUSPECTED TAXOTERE SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Taxotere. The information is not vetted and should not be considered as verified clinical evidence.
Possible Taxotere side effects / adverse reactions in 49 year old female
Reported by a physician from Germany on 2011-10-03
Patient: 49 year old female weighing 58.0 kg (127.6 pounds)
Reactions: Acute Stress Disorder, Suicidal Ideation
Adverse event resulted in: hospitalization
Suspect drug(s):
Taxotere
Other drugs received by patient: Cyclophosphamide; Epirubicin; Cyclophosphamide; Epirubicin
Possible Taxotere side effects / adverse reactions in 74 year old male
Reported by a physician from United States on 2011-10-03
Patient: 74 year old male
Reactions: Death
Adverse event resulted in: death
Suspect drug(s):
Radiotherapy
Indication: Prostate Cancer
Casodex
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-12-27
Lupron
Indication: Prostate Cancer
Start date: 2010-12-29
Taxotere
Indication: Prostate Cancer
Other drugs received by patient: Lasix; Phenazopyridine HCL TAB; Mucinex; Aspirin; Albuterol Sulfate; Flonase; Lisinopril; Dakin; Coreg; Potassium Cloride; Lexapro; Multaq; Zofran; Advair Diskus 100/50; Flomax
Possible Taxotere side effects / adverse reactions in 31 year old female
Reported by a consumer/non-health professional from Ireland on 2011-10-04
Patient: 31 year old female
Reactions: Somnolence, Abdominal Pain Upper, Fatigue, Amniotic Fluid Volume Decreased, Cough, Epistaxis, Stomatitis, Vomiting, Maternal Exposure During Pregnancy, Rhinorrhoea, Paraesthesia, Haemoglobin Decreased, Insomnia, Visual Impairment, Lacrimation Increased, Premature Delivery
Adverse event resulted in: hospitalization
Suspect drug(s):
Trastuzumab
Start date: 2011-08-15
Taxotere
Indication: Breast Cancer Stage IV
Start date: 2011-07-25
Trastuzumab
Indication: Breast Cancer Stage IV
Start date: 2011-07-25
End date: 2011-08-15
Other drugs received by patient: ALL Other Therapeutic Products; Corticosteroid NOS
|